The Interdisciplinary Autoimmune Summit 2018 (IAS), the nation’s leading autoimmune conference and exhibition, comes to Boston April 27 to 29 and will be held at the Westin Boston Waterfront Hotel. IAS 2018 is the only event of its kind that brings together rheumatologists, dermatologists, gastroenterologists, immunologists, internists, and other health care providers to debate, discuss, and collaborate on optimal treatment strategies for immune-mediated inflammatory diseases (IMIDs).
The agenda includes a wide array of IMID areas. Lilly Stairs, head of Patient Advocacy Clara Health Board Member American Autoimmune Related Diseases Association, will share her experiences in the Patient Perspective: Living Life with Multiple Immune-Mediated Inflammatory Diseases keynote speaker address.
Other sessions of interest to dermatologists include presentations by Joel M. Gelfand, MD, MSCE, of the University of Pennsylvania Perelman School of Medicine, who will speak about New Advances in the Treatment of Moderate to Severe Psoriasis and New Advances in the Impact of Anti-Inflammatory Treatment on Cardiovascular Risk. Joseph F. Merola, MD, MMSc, FAAD, FACR, of Harvard Medical School, will discussed Psoriatic Arthritis New Choices and Treatment Options.
For more information and to register, please visit https://www.iasmeeting.com/.
The Interdisciplinary Autoimmune Summit 2018 (IAS), the nation’s leading autoimmune conference and exhibition, comes to Boston April 27 to 29 and will be held at the Westin Boston Waterfront Hotel. IAS 2018 is the only event of its kind that brings together rheumatologists, dermatologists, gastroenterologists, immunologists, internists, and other health care providers to debate, discuss, and collaborate on optimal treatment strategies for immune-mediated inflammatory diseases (IMIDs).
The agenda includes a wide array of IMID areas. Lilly Stairs, head of Patient Advocacy Clara Health Board Member American Autoimmune Related Diseases Association, will share her experiences in the Patient Perspective: Living Life with Multiple Immune-Mediated Inflammatory Diseases keynote speaker address.
Other sessions of interest to dermatologists include presentations by Joel M. Gelfand, MD, MSCE, of the University of Pennsylvania Perelman School of Medicine, who will speak about New Advances in the Treatment of Moderate to Severe Psoriasis and New Advances in the Impact of Anti-Inflammatory Treatment on Cardiovascular Risk. Joseph F. Merola, MD, MMSc, FAAD, FACR, of Harvard Medical School, will discussed Psoriatic Arthritis New Choices and Treatment Options.
For more information and to register, please visit https://www.iasmeeting.com/.
The Interdisciplinary Autoimmune Summit 2018 (IAS), the nation’s leading autoimmune conference and exhibition, comes to Boston April 27 to 29 and will be held at the Westin Boston Waterfront Hotel. IAS 2018 is the only event of its kind that brings together rheumatologists, dermatologists, gastroenterologists, immunologists, internists, and other health care providers to debate, discuss, and collaborate on optimal treatment strategies for immune-mediated inflammatory diseases (IMIDs).
The agenda includes a wide array of IMID areas. Lilly Stairs, head of Patient Advocacy Clara Health Board Member American Autoimmune Related Diseases Association, will share her experiences in the Patient Perspective: Living Life with Multiple Immune-Mediated Inflammatory Diseases keynote speaker address.
Other sessions of interest to dermatologists include presentations by Joel M. Gelfand, MD, MSCE, of the University of Pennsylvania Perelman School of Medicine, who will speak about New Advances in the Treatment of Moderate to Severe Psoriasis and New Advances in the Impact of Anti-Inflammatory Treatment on Cardiovascular Risk. Joseph F. Merola, MD, MMSc, FAAD, FACR, of Harvard Medical School, will discussed Psoriatic Arthritis New Choices and Treatment Options.
For more information and to register, please visit https://www.iasmeeting.com/.
